Neurotrophic Effect of Asiatic acid, a Triterpene of Centella asiatica Against Chronic 1-Methyl 4-Phenyl 1, 2, 3, 6-Tetrahydropyridine Hydrochloride/Probenecid Mouse Model of Parkinson’s disease

The Role of MAPK, PI3K-Akt-GSK3β and mTOR Signalling Pathways

Jagatheesan Nataraj, Thamilarasan Manivasagam, Arokiasamy Justin Thenmozhi, Musthafa Mohamed Essa

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Regulation of various signalling (Ras-MAPK, PI3K and AKT) pathways by augmented activity of neurotrophic factors (NTFs) could prevent or halt the progress of dopaminergic loss in Parkinson’s disease (PD). Various in vitro and in vivo experimental studies indicated anti-parkinsonic potential of asiatic acid (AA), a pentacyclic triterpene obtained from Centella asiatica. So the present study is designed to determine the neurotrophic effect of AA against 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine hydrochloride/probenecid (MPTP/p) neurotoxicity in mice model of PD. AA treatment for 5 weeks significantly attenuated MPTP/p induced motor abnormalities, dopamine depletion and diminished expressions NTFs and tyrosine kinase receptors (TrKB). We further, revealed that AA treatment significantly inhibited the MPTP/p-induced phosphorylation of MAPK/P38 related proteins such as JNK and ERK. Moreover, AA treatment increased the phosphorylation of PI3K, Akt, GSK-3β and mTOR, suggesting that AA activated PI3K/Akt/mTOR signalling pathway, which might be the cause of neuroprotection offered by AA. The present findings provided more elaborate in vivo evidences to support the neuroprotective effect of AA on dopaminergic neurons of chronic Parkinson’s disease mouse model and the potential of AA to be developed as a possible new therapeutic target to treat PD.

Original languageEnglish
Pages (from-to)1354-1365
Number of pages12
JournalNeurochemical Research
Volume42
Issue number5
DOIs
Publication statusPublished - May 1 2017

Fingerprint

Centella
Probenecid
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Triterpenes
Phosphatidylinositol 3-Kinases
Parkinson Disease
Phosphorylation
Nerve Growth Factors
Pentacyclic Triterpenes
Glycogen Synthase Kinase 3
asiatic acid
Dopaminergic Neurons
Receptor Protein-Tyrosine Kinases
Neuroprotective Agents
p38 Mitogen-Activated Protein Kinases
Neurons
Dopamine
Chronic Disease

Keywords

  • Apoptosis
  • Asiatic acid
  • MPTP/p
  • NTFs
  • Parkinson’s disease
  • PI3K/Akt

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

@article{e3fd008e8e2d4b55bfc4267bbbc9254d,
title = "Neurotrophic Effect of Asiatic acid, a Triterpene of Centella asiatica Against Chronic 1-Methyl 4-Phenyl 1, 2, 3, 6-Tetrahydropyridine Hydrochloride/Probenecid Mouse Model of Parkinson’s disease: The Role of MAPK, PI3K-Akt-GSK3β and mTOR Signalling Pathways",
abstract = "Regulation of various signalling (Ras-MAPK, PI3K and AKT) pathways by augmented activity of neurotrophic factors (NTFs) could prevent or halt the progress of dopaminergic loss in Parkinson’s disease (PD). Various in vitro and in vivo experimental studies indicated anti-parkinsonic potential of asiatic acid (AA), a pentacyclic triterpene obtained from Centella asiatica. So the present study is designed to determine the neurotrophic effect of AA against 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine hydrochloride/probenecid (MPTP/p) neurotoxicity in mice model of PD. AA treatment for 5 weeks significantly attenuated MPTP/p induced motor abnormalities, dopamine depletion and diminished expressions NTFs and tyrosine kinase receptors (TrKB). We further, revealed that AA treatment significantly inhibited the MPTP/p-induced phosphorylation of MAPK/P38 related proteins such as JNK and ERK. Moreover, AA treatment increased the phosphorylation of PI3K, Akt, GSK-3β and mTOR, suggesting that AA activated PI3K/Akt/mTOR signalling pathway, which might be the cause of neuroprotection offered by AA. The present findings provided more elaborate in vivo evidences to support the neuroprotective effect of AA on dopaminergic neurons of chronic Parkinson’s disease mouse model and the potential of AA to be developed as a possible new therapeutic target to treat PD.",
keywords = "Apoptosis, Asiatic acid, MPTP/p, NTFs, Parkinson’s disease, PI3K/Akt",
author = "Jagatheesan Nataraj and Thamilarasan Manivasagam and {Justin Thenmozhi}, Arokiasamy and Essa, {Musthafa Mohamed}",
year = "2017",
month = "5",
day = "1",
doi = "10.1007/s11064-017-2183-2",
language = "English",
volume = "42",
pages = "1354--1365",
journal = "Neurochemical Research",
issn = "0364-3190",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Neurotrophic Effect of Asiatic acid, a Triterpene of Centella asiatica Against Chronic 1-Methyl 4-Phenyl 1, 2, 3, 6-Tetrahydropyridine Hydrochloride/Probenecid Mouse Model of Parkinson’s disease

T2 - The Role of MAPK, PI3K-Akt-GSK3β and mTOR Signalling Pathways

AU - Nataraj, Jagatheesan

AU - Manivasagam, Thamilarasan

AU - Justin Thenmozhi, Arokiasamy

AU - Essa, Musthafa Mohamed

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Regulation of various signalling (Ras-MAPK, PI3K and AKT) pathways by augmented activity of neurotrophic factors (NTFs) could prevent or halt the progress of dopaminergic loss in Parkinson’s disease (PD). Various in vitro and in vivo experimental studies indicated anti-parkinsonic potential of asiatic acid (AA), a pentacyclic triterpene obtained from Centella asiatica. So the present study is designed to determine the neurotrophic effect of AA against 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine hydrochloride/probenecid (MPTP/p) neurotoxicity in mice model of PD. AA treatment for 5 weeks significantly attenuated MPTP/p induced motor abnormalities, dopamine depletion and diminished expressions NTFs and tyrosine kinase receptors (TrKB). We further, revealed that AA treatment significantly inhibited the MPTP/p-induced phosphorylation of MAPK/P38 related proteins such as JNK and ERK. Moreover, AA treatment increased the phosphorylation of PI3K, Akt, GSK-3β and mTOR, suggesting that AA activated PI3K/Akt/mTOR signalling pathway, which might be the cause of neuroprotection offered by AA. The present findings provided more elaborate in vivo evidences to support the neuroprotective effect of AA on dopaminergic neurons of chronic Parkinson’s disease mouse model and the potential of AA to be developed as a possible new therapeutic target to treat PD.

AB - Regulation of various signalling (Ras-MAPK, PI3K and AKT) pathways by augmented activity of neurotrophic factors (NTFs) could prevent or halt the progress of dopaminergic loss in Parkinson’s disease (PD). Various in vitro and in vivo experimental studies indicated anti-parkinsonic potential of asiatic acid (AA), a pentacyclic triterpene obtained from Centella asiatica. So the present study is designed to determine the neurotrophic effect of AA against 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine hydrochloride/probenecid (MPTP/p) neurotoxicity in mice model of PD. AA treatment for 5 weeks significantly attenuated MPTP/p induced motor abnormalities, dopamine depletion and diminished expressions NTFs and tyrosine kinase receptors (TrKB). We further, revealed that AA treatment significantly inhibited the MPTP/p-induced phosphorylation of MAPK/P38 related proteins such as JNK and ERK. Moreover, AA treatment increased the phosphorylation of PI3K, Akt, GSK-3β and mTOR, suggesting that AA activated PI3K/Akt/mTOR signalling pathway, which might be the cause of neuroprotection offered by AA. The present findings provided more elaborate in vivo evidences to support the neuroprotective effect of AA on dopaminergic neurons of chronic Parkinson’s disease mouse model and the potential of AA to be developed as a possible new therapeutic target to treat PD.

KW - Apoptosis

KW - Asiatic acid

KW - MPTP/p

KW - NTFs

KW - Parkinson’s disease

KW - PI3K/Akt

UR - http://www.scopus.com/inward/record.url?scp=85011923794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011923794&partnerID=8YFLogxK

U2 - 10.1007/s11064-017-2183-2

DO - 10.1007/s11064-017-2183-2

M3 - Article

VL - 42

SP - 1354

EP - 1365

JO - Neurochemical Research

JF - Neurochemical Research

SN - 0364-3190

IS - 5

ER -